Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trane Technologies
TT
|
+$169M |
| 2 |
AbbVie
ABBV
|
+$155M |
| 3 |
Otis Worldwide
OTIS
|
+$127M |
| 4 |
Blackrock
BLK
|
+$110M |
| 5 |
Alibaba
BABA
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$372M |
| 2 |
RTN
Raytheon Company
RTN
|
+$235M |
| 3 |
Apple
AAPL
|
+$143M |
| 4 |
Microsoft
MSFT
|
+$90.5M |
| 5 |
McDonald's
MCD
|
+$56.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.87% |
| 2 | Healthcare | 13.29% |
| 3 | Financials | 12.68% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Prothena Corp
PRTA
$450M
| $84K | ﹤0.01% |
8,036
-858
| -10% | -$9.53K |
|
2577
Qfin Holdings
QFIN
$1.61B
| $84K | ﹤0.01% |
7,866
+2,966
| +61% | +$27K |
|
|
NPTN
2578
DELISTED
NEOPHOTONICS CORP
NPTN
| $84K | ﹤0.01% |
9,379
+4,758
| +103% | +$41K |
|
2579
Dime Commercial Bancshares
DCOM
$1.78B
| $83K | ﹤0.01% |
3,621
+168
| +5% | +$3.45K |
|
|
ACRE
2580
Ares Commercial Real Estate
ACRE
$270M
| $82K | ﹤0.01% |
8,942
| – | – |
|
2581
Bally's
BALY
$658M
| $82K | ﹤0.01% |
3,688
+6
| +0.2% | +$106 |
|
2582
SI-BONE Inc
SIBN
$834M
| $82K | ﹤0.01% |
5,090
+2,025
| +66% | +$31.9K |
|
2583
Winmark
WINA
$1.32B
| $82K | ﹤0.01% |
478
+58
| +14% | +$8.48K |
|
|
BMTC
2584
DELISTED
Bryn Mawr Bank Corp
BMTC
| $82K | ﹤0.01% |
2,998
| – | – |
|
|
DX
2585
Dynex Capital
DX
$3.21B
| $81K | ﹤0.01% |
5,641
+328
| +6% | +$4.39K |
|
2586
iHeartMedia
IHRT
$583M
| $81K | ﹤0.01% |
9,716
+7,589
| +357% | +$59.1K |
|
2587
NVE Corp
NVEC
$609M
| $81K | ﹤0.01% |
1,324
| – | – |
|
2588
Zentalis Pharmaceuticals
ZNTL
$302M
| $81K | ﹤0.01% |
+1,679
| New | +$64.4K |
|
|
PDLI
2589
DELISTED
PDL BioPharma, Inc.
PDLI
| $81K | ﹤0.01% |
27,872
| – | – |
|
2590
Ecovyst
ECVT
$1.14B
| $80K | ﹤0.01% |
6,035
+478
| +9% | +$5.62K |
|
|
EFC
2591
Ellington Financial
EFC
$1.71B
| $80K | ﹤0.01% |
6,825
+532
| +8% | +$5.4K |
|
2592
Puma Biotechnology
PBYI
$454M
| $80K | ﹤0.01% |
7,681
+97
| +1% | +$1K |
|
|
CFB
2593
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $80K | ﹤0.01% |
8,180
+2,393
| +41% | +$21.9K |
|
|
HONE
2594
DELISTED
HarborOne Bancorp
HONE
| $79K | ﹤0.01% |
9,220
+2,745
| +42% | +$22K |
|
2595
PAR Technology
PAR
$735M
| $79K | ﹤0.01% |
2,643
+672
| +34% | +$14.7K |
|
|
TRTX
2596
TPG RE Finance Trust
TRTX
$618M
| $78K | ﹤0.01% |
9,054
+1,358
| +18% | +$9.86K |
|
|
BSTC
2597
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $78K | ﹤0.01% |
1,279
-19
| -1% | -$1.1K |
|
2598
Beam Therapeutics
BEAM
$2.84B
| $77K | ﹤0.01% |
2,731
+824
| +43% | +$17.8K |
|
2599
Compugen
CGEN
$228M
| $77K | ﹤0.01% |
+5,109
| New | +$69K |
|
|
RVI
2600
DELISTED
Retail Value Inc. Common Shares
RVI
| $77K | ﹤0.01% |
68,450
-8,879
| -11% | -$10.1K |
|
Similar funds
Legal & General Group's Q2 2020 Portfolio in Review
As of Q2 2020, Legal & General Group held 3,579 positions worth $207B, up 21% from $171B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Legal & General Group's Q2 2020 filing shows 222 new, 1,974 increased, 815 reduced and 175 closed positions. Its largest new stake was Otis Worldwide: 2,441,915 shares worth $139M. The largest sale was Allergan plc, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Legal & General Group's largest Q2 2020 buy was Otis Worldwide: 2,441,915 shares worth $139M.
- Legal & General Group added most to Trane Technologies in Q2 2020, an estimated $169M increase.
- Legal & General Group's biggest Q2 2020 reduction was Apple, cutting an estimated $143M.
- Legal & General Group fully exited Allergan plc in Q2 2020, selling an estimated $372M.
- Legal & General Group's ten largest holdings make up 21% of its $207B portfolio in Q2 2020.
- Legal & General Group opened 222 new positions and closed 175 in Q2 2020.
- Legal & General Group's portfolio value rose 21% quarter-over-quarter to $207B.
Based on Legal & General Group's 13F filing for Q2 2020, filed 14 Aug 2020.